Using protein biomarkers to develop personalized cancer treatment

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=nLpOxGxOGZ0

The team in Munich developed a method to isolate proteins from FFPE samples, using our liquid handling robot epMotion. These potential tumor tissue samples from surgery are processed for identification of abnormal signaling proteins as biomarkers. • Shown is the work of the Pathology lab in Hospital rechts der Isar - Institute of Pathology, Technische Universität München, Munich, Germany, who is the second winner of the World of epMotion user contest. • The epMotion fits perfectly in the workflow because: (1) it guaranties accurate and reproducible pipetting of protein lysate dilutions curves; (2) it is very flexible and can pipette even complex patterns in 384 well plates compatible to a large number of different robotic spotting systems; (4) it is a robust device; (5) it is time saving and supports the automation of the entire workflow. • More information: https://www.eppendorf.com/epmotion

#############################

New on site